Detailansicht

Wissensnetz

Person

Andrea Wittig (1971-)

Fachärztin für Strahlentherapie

Name	Andrea Wittig
Zeit	1971- (Lebensdaten)
Ort	Jena (Wirkungsort) Deutschland
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Fachärztin für Strahlentherapie (charakteristischer Beruf)
Variante	A. Wittig
Beziehung	Klinik für Strahlentherapie und Radioonkologie (Jena) Universitätsklinikum Jena
Weitere Angaben	Dissertation, Universität Essen, 2002
Datensatztyp	Person
GND-Nummer	141457325
Datensatz-ID	141457325
Beteiligt an alle anzeigen Metastasis-directed stereotactic radiotherapy in patients with breast cancer: results of an international multicenter cohort study Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy" Überlebensraten beim Prostatakarzinom in Abhängigkeit der Primärtherapie : eine registerbasierte Auswertung Stereotactic body radiotherapy of adrenal metastases — a dose‐finding study Hirnmetastasen beim Mammakarzinom : Auftreten, Therapie und Prognose der letzten 10 Jahre : Zuarbeit zur Studie GBG79 Brainmet Register aus den Daten des Tumorzentrums Gera Stereotactic or conformal radiotherapy for adrenal metastases: patient characteristics and outcomes in a multicenter analysis Dual PI3K/mTOR inhibitor NVP-BEZ235 enhances radiosensitivity of head and neck squamous cell carcinoma (HNSCC) cell lines due to suppressed Double-Strand Break (DSB) repair by non-homologous end joining The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases Ergebnisse der modernen organerhaltenden Radiochemotherapie des Harnblasenkarzinoms Long-term follow-up and patterns of recurrence of patients with oligometastatic NSCLC treated with pulmonary SBRT The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases Histology as predictor for outcome following SBRT in NSCLC patients with lung oligo-metastases Repeat sbrt for pulmonary oligo-metastases Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma: a multicenter analysis of the German working group “Stereotactic Radiotherapy” Bayesian cure rate modeling of local tumor control: evaluation in stereotactic body radiation therapy for pulmonary metastases Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy" Quantifizierung von Effekten bei der Kombination von Bestrahlung und Medikamenten in vitro

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Andrea Wittig (1971-)

Metastasis-directed stereotactic radiotherapy in patients with breast cancer: results of an international multicenter cohort study

Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy"

Überlebensraten beim Prostatakarzinom in Abhängigkeit der Primärtherapie : eine registerbasierte Auswertung

Stereotactic body radiotherapy of adrenal metastases — a dose‐finding study

Hirnmetastasen beim Mammakarzinom : Auftreten, Therapie und Prognose der letzten 10 Jahre : Zuarbeit zur Studie GBG79 Brainmet Register aus den Daten des Tumorzentrums Gera

Stereotactic or conformal radiotherapy for adrenal metastases: patient characteristics and outcomes in a multicenter analysis

Dual PI3K/mTOR inhibitor NVP-BEZ235 enhances radiosensitivity of head and neck squamous cell carcinoma (HNSCC) cell lines due to suppressed Double-Strand Break (DSB) repair by non-homologous end joining

The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases

Ergebnisse der modernen organerhaltenden Radiochemotherapie des Harnblasenkarzinoms

Long-term follow-up and patterns of recurrence of patients with oligometastatic NSCLC treated with pulmonary SBRT

The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases

Histology as predictor for outcome following SBRT in NSCLC patients with lung oligo-metastases

Repeat sbrt for pulmonary oligo-metastases

Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy

Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease

Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma: a multicenter analysis of the German working group “Stereotactic Radiotherapy”

Bayesian cure rate modeling of local tumor control: evaluation in stereotactic body radiation therapy for pulmonary metastases

Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy

Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"

Quantifizierung von Effekten bei der Kombination von Bestrahlung und Medikamenten in vitro